2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Classical hematology
2
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
16
Multiple Myeloma
13
Neoplasms
12
Colorectal Neoplasms
8
Neoplasms, Plasma Cell
7
Myelodysplastic Syndromes
7
Leukemia, Myeloid, Acute
6
Glioblastoma
5
Sarcoma
4
Prostatic Neoplasms
4
Leukemia, Myelomonocytic, Chronic
4
Carcinoma, Non-Small-Cell Lung
4
Breast Neoplasms
4
Skin Neoplasms
3
Inflammation
3
Colonic Neoplasms
3
Stomatitis
2
Stomach Neoplasms
2
Recurrence
2
Primary Myelofibrosis
2
Ovarian Neoplasms
2
Neoplasms by Site
2
Myofibroma
2
Myeloproliferative Disorders
2
Lymphoma
2
Lung Neoplasms
2
Liver Neoplasms
2
Leukemia
2
Glioma
2
Frailty
2
Interventions
Epoetin Alfa
55
Darbepoetin alfa
39
epoetin beta
14
ferric carboxymaltose
11
Lenalidomide
5
Cyclophosphamide
5
luspatercept
4
fludarabine phosphate
4
fludarabine
4
Erythropoietin
4
Cyclosporine
4
Cisplatin
4
Busulfan
4
Blood Transfusion
4
Biopsy
4
ACE-011
4
peginesatide
3
iron isomaltoside 1000
3
hematide
3
ferrous sulfate
3
ferric gluconate
3
Radiotherapy
3
Iron-Dextran Complex
3
Filgrastim
3
Ferric Oxide, Saccharated
3
Erythrocyte Transfusion
3
Antilymphocyte Serum
3
thymoglobulin
2
telapristone acetate
2
ruxolitinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Anemia
×
Ascorbic Acid
×
Clear all
NCT06018883
2025-08-07
PTCA199-3
Fudan University
Phase 3
Active not recruiting
100 enrolled
NCT06018896
2024-06-06
PTCA199-4
Fudan University
Phase 2
Recruiting
20 enrolled